Perspective: defects in cell cycle control and cancer
- PMID: 10341710
- DOI: 10.1002/(SICI)1096-9896(199901)187:1<95::AID-PATH249>3.0.CO;2-#
Perspective: defects in cell cycle control and cancer
Abstract
The past several years have witnessed a dramatic accumulation of experimental and clinical evidence supporting the notion that the cell cycle machinery is commonly targeted on oncogenesis. While numerous cell cycle regulators qualify as proto-oncogenes or tumour suppressors and their aberrations may provide direct proliferative advantage to cancer cells, defects in checkpoint mechanisms act more indirectly yet affect both tumour progression and response to anticancer therapy. In this review, the ways that cell cycle defects contribute to oncogenesis are briefly illustrated and the emerging benefits of the newly gained insights into the cell cycle clock for clinical oncology are critically considered. Given the many reviews on the subject, emphasis is put on concepts rather than comprehensive treatment of the selected topics, with particular attention given to controversial issues, unorthodox phenomena, and the challenge facing the 'cell cycle and cancer field' at the transition to the next millennium.
Similar articles
-
[Cell cycle and cancer--from the tumor cell line to the patient].Praxis (Bern 1994). 2000 Mar 9;89(11):435-7. Praxis (Bern 1994). 2000. PMID: 10758729 Review. German.
-
Cyclins, CDKs and cancer.Semin Cancer Biol. 1995 Apr;6(2):63-72. doi: 10.1006/scbi.1995.0009. Semin Cancer Biol. 1995. PMID: 7647308 Review.
-
Cell cycle deregulation: a common motif in cancer.Prog Cell Cycle Res. 2003;5:5-18. Prog Cell Cycle Res. 2003. PMID: 14593696 Review.
-
Human cytomegalovirus pp71: a new viral tool to probe the mechanisms of cell cycle progression and oncogenesis controlled by the retinoblastoma family of tumor suppressors.J Cell Biochem. 2004 Sep 1;93(1):37-45. doi: 10.1002/jcb.20177. J Cell Biochem. 2004. PMID: 15352160 Review.
-
Deregulation of cell growth and malignant transformation.Croat Med J. 2005 Aug;46(4):622-38. Croat Med J. 2005. PMID: 16100767 Review.
Cited by
-
Molecular alterations associated with prostate cancer.Cent European J Urol. 2018;71(2):168-176. doi: 10.5173/ceju.2018.1583. Epub 2018 Mar 16. Cent European J Urol. 2018. PMID: 30038806 Free PMC article. Review.
-
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.Am J Pathol. 2003 Feb;162(2):655-63. doi: 10.1016/S0002-9440(10)63859-X. Am J Pathol. 2003. PMID: 12547723 Free PMC article.
-
Cell Division Cycle-Associated Genes Are Potential Immune Regulators in Nasopharyngeal Carcinoma.Front Oncol. 2022 Feb 14;12:779175. doi: 10.3389/fonc.2022.779175. eCollection 2022. Front Oncol. 2022. PMID: 35237510 Free PMC article.
-
The phosphatase CTDSPL2 is phosphorylated in mitosis and a target for restraining tumor growth and motility in pancreatic cancer.Cancer Lett. 2022 Feb 1;526:53-65. doi: 10.1016/j.canlet.2021.11.018. Epub 2021 Nov 20. Cancer Lett. 2022. PMID: 34813892 Free PMC article.
-
New insights into the pathology and molecular biology of human germ cell tumors.World J Urol. 2004 Apr;22(1):15-24. doi: 10.1007/s00345-004-0399-7. Epub 2004 Mar 20. World J Urol. 2004. PMID: 15042404 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous